Aravind Asokan - Publications

Affiliations: 
Biochemistry and Biophysics University of North Carolina, Chapel Hill, Chapel Hill, NC 
Area:
General Biophysics, Biochemistry, Virology Biology

108/195 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Barzi M, Chen T, Gonzalez TJ, Pankowicz FP, Oh SH, Streff HL, Rosales A, Ma Y, Collias S, Woodfield SE, Diehl AM, Vasudevan SA, Galvan TN, Goss J, Gersbach CA, ... ... Asokan A, et al. A humanized mouse model for adeno-associated viral gene therapy. Nature Communications. 15: 1955. PMID 38438373 DOI: 10.1038/s41467-024-46017-0  0.302
2024 Clements KN, Gonzalez TJ, Asokan A. Engineering Synthetic circRNAs for Efficient CNS Expression. Methods in Molecular Biology (Clifton, N.J.). 2765: 227-246. PMID 38381343 DOI: 10.1007/978-1-0716-3678-7_13  0.31
2023 Asokan A, Shen S. Redirecting AAV vectors to extrahepatic tissues. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 37805712 DOI: 10.1016/j.ymthe.2023.10.005  0.584
2023 Gonzalez TJ, Mitchell-Dick A, Blondel LO, Fanous MM, Hull JA, Oh DK, Moller-Tank S, Castellanos Rivera RM, Piedrahita JA, Asokan A. Structure-guided AAV capsid evolution strategies for enhanced CNS gene delivery. Nature Protocols. PMID 37735235 DOI: 10.1038/s41596-023-00875-y  0.328
2023 Smith TJ, Fusco RM, Elmore ZC, Asokan A. Interplay between Furin and Sialoglycans in Modulating Adeno-Associated Viral Cell Entry. Journal of Virology. e0009323. PMID 37097176 DOI: 10.1128/jvi.00093-23  0.385
2022 Yan R, Cigliola V, Oonk KA, Petrover Z, DeLuca S, Wolfson DW, Vekstein A, Mendiola MA, Devlin G, Bishawi M, Gemberling MP, Sinha T, Sargent MA, York AJ, Shakked A, ... ... Asokan A, et al. An enhancer-based gene-therapy strategy for spatiotemporal control of cargoes during tissue repair. Cell Stem Cell. PMID 36516837 DOI: 10.1016/j.stem.2022.11.012  0.303
2022 Gonzalez TJ, Simon KE, Blondel LO, Fanous MM, Roger AL, Maysonet MS, Devlin GW, Smith TJ, Oh DK, Havlik LP, Castellanos Rivera RM, Piedrahita JA, ElMallah MK, Gersbach CA, Asokan A. Cross-species evolution of a highly potent AAV variant for therapeutic gene transfer and genome editing. Nature Communications. 13: 5947. PMID 36210364 DOI: 10.1038/s41467-022-33745-4  0.359
2021 Elmore ZC, Patrick Havlik L, Oh DK, Anderson L, Daaboul G, Devlin GW, Vincent HA, Asokan A. The membrane associated accessory protein is an adeno-associated viral egress factor. Nature Communications. 12: 6239. PMID 34716331 DOI: 10.1038/s41467-021-26485-4  0.32
2021 Havlik LP, Das A, Mietzsch M, Oh DK, Ark J, McKenna R, Agbandje-McKenna M, Asokan A. Receptor switching in newly evolved adeno-associated viruses. Journal of Virology. JVI0058721. PMID 34232726 DOI: 10.1128/JVI.00587-21  0.309
2021 Hunanyan AS, Kantor B, Puranam RS, Elliott C, McCall A, Dhindsa J, Pagadala P, Wallace K, Poe J, Gunduz T, Asokan A, Koeberl DD, ElMallah MK, Mikati MA. Adeno-Associated Virus-Mediated Gene Therapy in the Mashlool, , Mouse Model of Alternating Hemiplegia of Childhood. Human Gene Therapy. PMID 33577387 DOI: 10.1089/hum.2020.191  0.323
2020 Kwon JB, Ettyreddy AR, Vankara A, Bohning JD, Devlin G, Hauschka SD, Asokan A, Gersbach CA. Gene Editing of Muscle Stem Cells with Adeno-Associated Viral Vectors in a Mouse Model of Duchenne Muscular Dystrophy. Molecular Therapy. Methods & Clinical Development. 19: 320-329. PMID 33145368 DOI: 10.1016/j.omtm.2020.09.016  0.301
2020 Elmore ZC, Oh DK, Simon KE, Fanous MM, Asokan A. Rescuing AAV gene transfer from neutralizing antibodies with an IgG-degrading enzyme. Jci Insight. PMID 32941184 DOI: 10.1172/Jci.Insight.139881  0.41
2020 Madigan VJ, Berry GE, Tyson TO, Nardone-White D, Ark J, Elmore ZC, Murlidharan G, Vincent HA, Asokan A. The Golgi calcium ATPase pump plays an essential role in AAV trafficking and transduction. Journal of Virology. PMID 32817219 DOI: 10.1128/Jvi.01604-20  0.345
2020 Havlik LP, Simon KE, Smith JK, Klinc KA, Tse LV, Oh DK, Fanous MM, Meganck RM, Mietzsch M, Agbandje-McKenna M, Asokan A. Co-evolution of AAV capsid antigenicity and tropism through a structure-guided approach. Journal of Virology. PMID 32669336 DOI: 10.1128/Jvi.00976-20  0.434
2020 Li J, Li Y, Wang J, Gonzalez TJ, Asokan A, Napierala J, Napierala M. Defining transcription regulatory elements in the human frataxin gene: implications for gene therapy. Human Gene Therapy. PMID 32527155 DOI: 10.1089/Hum.2020.053  0.398
2020 Das A, Barrientos R, Shiota T, Madigan V, Misumi I, McKnight KL, Sun L, Li Z, Meganck RM, Li Y, Kaluzna E, Asokan A, Whitmire JK, Kapustina M, Zhang Q, et al. Gangliosides are essential endosomal receptors for quasi-enveloped and naked hepatitis A virus. Nature Microbiology. PMID 32451473 DOI: 10.1038/S41564-020-0727-8  0.401
2020 Huang Q, Cohen MA, Alsina FC, Devlin G, Garrett A, McKey J, Havlik P, Rakhilin N, Wang E, Xiang K, Mathews P, Wang L, Bock C, Ruthig V, Wang Y, ... ... Asokan A, et al. Intravital imaging of mouse embryos. Science (New York, N.Y.). 368: 181-186. PMID 32273467 DOI: 10.1126/Science.Aba0210  0.31
2019 Madigan VJ, Tyson TO, Yuziuk JA, Pillai M, Moller-Tank S, Asokan A. A CRISPR screen identifies the cell polarity determinant Crumbs 3 as an AAV restriction factor in hepatocytes. Journal of Virology. PMID 31391273 DOI: 10.1128/Jvi.00943-19  0.417
2019 Madigan VJ, Yuziuk JA, Chiarella AM, Tyson TO, Meganck RM, Elmore ZC, Tse LV, Hathaway NA, Asokan A. Ring finger protein 121 is a potent regulator of adeno-associated viral genome transcription. Plos Pathogens. 15: e1007988. PMID 31386698 DOI: 10.1371/Journal.Ppat.1007988  0.424
2019 Abdulhaqq SA, Wu H, Schell JB, Hammond KB, Reed JS, Legasse AW, Axthelm MK, Park BS, Asokan A, Früh K, Hansen SG, Picker LJ, Sacha JB. Vaccine-mediated Inhibition of the Transporter Associated with Antigen Processing is Insufficient to Induce MHC-E Restricted CD8+ T cells in Nonhuman Primates. Journal of Virology. PMID 31315990 DOI: 10.1128/Jvi.00592-19  0.3
2019 Albright BH, Simon KE, Pillai M, Devlin G, Asokan A. Modulation of sialic acid dependence influences the CNS transduction profile of adeno-associated viruses. Journal of Virology. PMID 30894463 DOI: 10.1128/Jvi.00332-19  0.452
2019 Nelson CE, Wu Y, Gemberling MP, Oliver ML, Waller MA, Bohning JD, Robinson-Hamm JN, Bulaklak K, Castellanos Rivera RM, Collier JH, Asokan A, Gersbach CA. Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophy. Nature Medicine. PMID 30778238 DOI: 10.1038/S41591-019-0344-3  0.345
2019 Castle MJ, Cheng Y, Asokan A, Tuszynski MH. IMPROVED INTRATHECAL VECTOR DELIVERY FOR GENE THERAPY IN ALZHEIMER’S DISEASE Alzheimer's & Dementia. 15: P1630. DOI: 10.1016/J.Jalz.2019.06.4868  0.367
2018 Castle MJ, Cheng Y, Asokan A, Tuszynski MH. Physical positioning markedly enhances brain transduction after intrathecal AAV9 infusion. Science Advances. 4: eaau9859. PMID 30443600 DOI: 10.1126/Sciadv.Aau9859  0.39
2018 Meganck RM, Borchardt EK, Castellanos Rivera RM, Scalabrino ML, Wilusz JE, Marzluff WF, Asokan A. Tissue-Dependent Expression and Translation of Circular RNAs with Recombinant AAV Vectors In Vivo. Molecular Therapy. Nucleic Acids. 13: 89-98. PMID 30245471 DOI: 10.1016/J.Omtn.2018.08.008  0.384
2018 Tse LV, Moller-Tank S, Meganck RM, Asokan A. Mapping and Engineering Functional Domains of the Assembly Activating Protein of Adeno-Associated Viruses. Journal of Virology. PMID 29695425 DOI: 10.1128/Jvi.00393-18  0.342
2018 Crowther AJ, Lim SA, Asrican B, Albright BH, Wooten J, Yeh CY, Bao H, Cerri DH, Hu J, Ian Shih YY, Asokan A, Song J. An Adeno-Associated Virus-Based Toolkit for Preferential Targeting and Manipulating Quiescent Neural Stem Cells in the Adult Hippocampus. Stem Cell Reports. PMID 29478897 DOI: 10.1016/J.Stemcr.2018.01.018  0.373
2017 Burwitz BJ, Wettengel JM, Mück-Häusl MA, Ringelhan M, Ko C, Festag MM, Hammond KB, Northrup M, Bimber BN, Jacob T, Reed JS, Norris R, Park B, Moller-Tank S, Esser K, ... ... Asokan A, et al. Hepatocytic expression of human sodium-taurocholate cotransporting polypeptide enables hepatitis B virus infection of macaques. Nature Communications. 8: 2146. PMID 29247188 DOI: 10.1038/S41467-017-01953-Y  0.342
2017 Albright BH, Storey CM, Murlidharan G, Castellanos Rivera RM, Berry GE, Madigan VJ, Asokan A. Mapping the Structural Determinants Required for AAVrh.10 Transport across the Blood-Brain Barrier. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 29175157 DOI: 10.1016/J.Ymthe.2017.10.017  0.422
2017 Tse LV, Klinc KA, Madigan VJ, Castellanos Rivera RM, Wells LF, Havlik LP, Smith JK, Agbandje-McKenna M, Asokan A. Structure-guided evolution of antigenically distinct adeno-associated virus variants for immune evasion. Proceedings of the National Academy of Sciences of the United States of America. PMID 28559317 DOI: 10.1073/Pnas.1704766114  0.407
2017 Zeng C, Moller-Tank S, Asokan A, Dragnea BG. Probing the Link between Genomic Cargo, Contact Mechanics and Nanoindentation in Recombinant Adeno-Associated Virus 2. The Journal of Physical Chemistry. B. PMID 28142241 DOI: 10.1021/Acs.Jpcb.6B10131  0.397
2016 Murlidharan G, Sakamoto K, Rao L, Corriher T, Wang D, Gao G, Sullivan P, Asokan A. CNS-restricted Transduction and CRISPR/Cas9-mediated Gene Deletion with an Engineered AAV Vector. Molecular Therapy. Nucleic Acids. 5: e338. PMID 28131242 DOI: 10.1038/mtna.2016.49  0.335
2016 Murlidharan G, Crowther A, Reardon RA, Song J, Asokan A. Glymphatic fluid transport controls paravascular clearance of AAV vectors from the brain. Jci Insight. 1: e88034. PMID 27699236 DOI: 10.1172/Jci.Insight.88034  0.423
2016 Berry GE, Asokan A. Cellular transduction mechanisms of adeno-associated viral vectors. Current Opinion in Virology. 21: 54-60. PMID 27544821 DOI: 10.1016/J.Coviro.2016.08.001  0.468
2016 Murlidharan G, Sakamoto K, Rao L, Corriher T, Wang D, Gao G, Sullivan P, Asokan A. CNS-restricted Transduction and CRISPR/Cas9-mediated Gene Deletion with an Engineered AAV Vector. Molecular Therapy. Nucleic Acids. 5: e338. PMID 27434683 DOI: 10.1038/Mtna.2016.49  0.438
2016 Tseng YS, Vliet KV, Rao L, McKenna R, Byrne BJ, Asokan A, Agbandje-McKenna M. Generation and characterization of anti-AAV8 and anti-AAV9 monoclonal antibodies. Journal of Virological Methods. PMID 27424005 DOI: 10.1016/J.Jviromet.2016.07.009  0.379
2016 Pierson EE, Keifer DZ, Asokan A, Jarrold MF. Resolving Adeno-Associated Viral Particle Diversity With Charge Detection Mass Spectrometry. Analytical Chemistry. PMID 27310298 DOI: 10.1021/Acs.Analchem.6B00883  0.343
2016 Madigan VJ, Asokan A. Engineering AAV receptor footprints for gene therapy. Current Opinion in Virology. 18: 89-96. PMID 27262111 DOI: 10.1016/J.Coviro.2016.05.001  0.417
2016 de Leeuw CN, Korecki AJ, Berry GE, Hickmott JW, Lam SL, Lengyell TC, Bonaguro RJ, Borretta LJ, Chopra V, Chou AY, D'Souza CA, Kaspieva O, Laprise S, McInerny SC, Portales-Casamar E, ... ... Asokan A, et al. rAAV-compatible MiniPromoters for restricted expression in the brain and eye. Molecular Brain. 9: 52. PMID 27164903 DOI: 10.1186/S13041-016-0232-4  0.405
2016 Huang LY, Patel A, Ng R, Miller EB, Halder S, McKenna R, Asokan A, Agbandje-McKenna M. Characterization of the Adeno-associated virus 1 and 6 sialic acid binding site. Journal of Virology. PMID 26962225 DOI: 10.1128/Jvi.00161-16  0.425
2016 Vance M, Llanga T, Bennett W, Woodard K, Murlidharan G, Chungfat N, Asokan A, Gilger B, Kurtzberg J, Samulski RJ, Hirsch ML. AAV Gene Therapy for MPS1-associated Corneal Blindness. Scientific Reports. 6: 22131. PMID 26899286 DOI: 10.1038/Srep22131  0.411
2016 Huang L, Patel A, Ng R, Miller EB, Halder S, McKenna R, Asokan A, Agbandje-McKenna M. 727. Characterizing the Adeno-Associated Virus 1 Sialic Receptor Binding Site and Its Overlap with Antigenic Epitopes Molecular Therapy. 24: S287. DOI: 10.1016/S1525-0016(16)33535-3  0.414
2016 Robinson-Hamm JN, Nelson CE, Rivera RMC, Aartsma-Rus A, Asokan A, Gersbach CA. 504. Restoration of Dystrophin Expression by Gene Editing with S. aureus Cas9 in Models of Duchenne Muscular Dystrophy Molecular Therapy. 24: S201. DOI: 10.1016/S1525-0016(16)33313-5  0.43
2016 Nelson C, Gemberling M, Hakim CH, Ousterout DG, Thakore PI, Castellanos RM, Madhavan S, Pan X, Ran FA, Yan W, Asokan A, Zhang F, Duan D, Gersbach CA. 482. Local and Systemic Gene Editing in a Mouse Model of Duchenne Muscular Dystrophy Molecular Therapy. 24: S191. DOI: 10.1016/S1525-0016(16)33291-9  0.385
2016 Murlidharan G, Asokan A. 55. Aquaporins and CSF Flux Are Critical Determinants of AAV Mediated CNS Gene Transfer Molecular Therapy. 24: S25. DOI: 10.1016/S1525-0016(16)32864-7  0.396
2016 Berry G, Murlidharan G, Asokan A. 30. Modulation of Intracellular Calcium Enhances AAV Transduction in the CNS Molecular Therapy. 24: S14. DOI: 10.1016/S1525-0016(16)32839-8  0.323
2016 Schreiber CA, Izumiya Y, Asokan A, Ikeda Y. 8. Further Characterization of U2 snRNP Mediated Restriction of AAV Vector Transduction Molecular Therapy. 24: S4-S5. DOI: 10.1016/S1525-0016(16)32817-9  0.455
2015 Nelson CE, Hakim CH, Ousterout DG, Thakore PI, Moreb EA, Rivera RM, Madhavan S, Pan X, Ran FA, Yan WX, Asokan A, Zhang F, Duan D, Gersbach CA. In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy. Science (New York, N.Y.). PMID 26721684 DOI: 10.1126/Science.Aad5143  0.403
2015 Berry GE, Asokan A. Chemical Modulation of Endocytic Sorting Augments Adeno-Associated Viral Transduction. The Journal of Biological Chemistry. PMID 26527686 DOI: 10.1074/Jbc.M115.687657  0.397
2015 Schreiber CA, Sakuma T, Izumiya Y, Holditch SJ, Hickey RD, Bressin RK, Basu U, Koide K, Asokan A, Ikeda Y. An siRNA Screen Identifies the U2 snRNP Spliceosome as a Host Restriction Factor for Recombinant Adeno-associated Viruses. Plos Pathogens. 11: e1005082. PMID 26244496 DOI: 10.1371/Journal.Ppat.1005082  0.441
2015 Li C, Wu S, Albright B, Hirsch M, Li W, Tseng YS, Agbandje-McKenna M, McPhee S, Asokan A, Samulski RJ. Development of Patient-specific AAV Vectors After Neutralizing Antibody Selection for Enhanced Muscle Gene Transfer. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 26220272 DOI: 10.1038/Mt.2015.134  0.415
2015 Tse LV, Moller-Tank S, Asokan A. Strategies to circumvent humoral immunity to adeno-associated viral vectors. Expert Opinion On Biological Therapy. 15: 845-55. PMID 25985812 DOI: 10.1517/14712598.2015.1035645  0.422
2015 Hemphill J, Borchardt EK, Brown K, Asokan A, Deiters A. Optical Control of CRISPR/Cas9 Gene Editing. Journal of the American Chemical Society. 137: 5642-5. PMID 25905628 DOI: 10.1021/Ja512664V  0.343
2015 Murlidharan G, Corriher T, Ghashghaei HT, Asokan A. Unique glycan signatures regulate adeno-associated virus tropism in the developing brain. Journal of Virology. 89: 3976-87. PMID 25631075 DOI: 10.1128/Jvi.02951-14  0.418
2015 Shen S, Berry GE, Castellanos Rivera RM, Cheung RY, Troupes AN, Brown SM, Kafri T, Asokan A. Functional analysis of the putative integrin recognition motif on adeno-associated virus 9. The Journal of Biological Chemistry. 290: 1496-504. PMID 25404742 DOI: 10.1074/Jbc.M114.608281  0.617
2015 Nelson CE, Moreb DGOJNREA, Castellanos RM, Ran FA, Yan W, Zhang F, Asokan A, Gersbach CA. 397. Correction of the Dystrophin Gene By the CRISPR/Cas9 System in a Mouse Model of Muscular Dystrophy Molecular Therapy. 23. DOI: 10.1016/S1525-0016(16)34006-0  0.435
2015 Albright BH, Madigan V, Rao L, Chiorini JA, Agbandje-McKenna M, Asokan A. 302. Combinatorial Engineering of a Receptor Footprint on AAV Serotype 4 Yields Novel Vectors Molecular Therapy. 23: S122. DOI: 10.1016/S1525-0016(16)33911-9  0.427
2015 Murlidharan G, Asokan A. 265. Polysialic Acid as a Novel Regulator of AAV Tropism in the Developing Brain Molecular Therapy. 23: S106. DOI: 10.1016/S1525-0016(16)33874-6  0.399
2015 Castellanos Rivera RM, Rao L, Murlidharan G, Corriher T, Asokan A. 194. Lymphatic Transport Mediates Systemic Leakage of Peripherally Administered AAV9 Vectors Molecular Therapy. 23: S77. DOI: 10.1016/S1525-0016(16)33799-6  0.428
2015 Rao L, Albright BH, Corriher T, Murlidharan G, Asokan A. 42. Differential Transduction Profiles of AAV Vectors in a Mouse Model of Human Glycosylation Molecular Therapy. 23: S18-S19. DOI: 10.1016/S1525-0016(16)33647-4  0.452
2015 Schreiber C, Sakuma T, Izumiya Y, Holditch S, Hickey R, Bressin R, Basu U, Koide K, Asokan A, Ikeda Y. 41. U2 snRNP Spliceosome Proteins Block Recombinant AAV Vector Transduction Molecular Therapy. 23: S18. DOI: 10.1016/S1525-0016(16)33646-2  0.465
2015 Berry GE, Asokan A. 38. Pharmacological Regulation of Vesicular Trafficking as a Strategy to Enhance Recombinant AAV Transduction Molecular Therapy. 23: S17. DOI: 10.1016/S1525-0016(16)33643-7  0.453
2015 Murlidharan G, Rao L, Wang D, Corriher T, Seok-Oh K, Gao G, Jude Samulski R, Tarantal AF, Asokan A. 14. Next Generation AAV Vectors for Limiting Systemic Leakage and Improving Safety Following CNS Administration Molecular Therapy. 23: S6. DOI: 10.1016/S1525-0016(16)33618-8  0.465
2014 Murlidharan G, Samulski RJ, Asokan A. Biology of adeno-associated viral vectors in the central nervous system. Frontiers in Molecular Neuroscience. 7: 76. PMID 25285067 DOI: 10.3389/Fnmol.2014.00076  0.429
2014 Pleticha J, Heilmann LF, Evans CH, Asokan A, Samulski RJ, Beutler AS. Preclinical toxicity evaluation of AAV for pain: evidence from human AAV studies and from the pharmacology of analgesic drugs. Molecular Pain. 10: 54. PMID 25183392 DOI: 10.1186/1744-8069-10-54  0.357
2014 Ishikawa K, Fish KM, Tilemann L, Rapti K, Aguero J, Santos-Gallego CG, Lee A, Karakikes I, Xie C, Akar FG, Shimada YJ, Gwathmey JK, Asokan A, McPhee S, Samulski J, et al. Cardiac I-1c overexpression with reengineered AAV improves cardiac function in swine ischemic heart failure. Molecular Therapy : the Journal of the American Society of Gene Therapy. 22: 2038-45. PMID 25023328 DOI: 10.1038/Mt.2014.127  0.317
2014 O'Reilly M, Federoff HJ, Fong Y, Kohn DB, Patterson AP, Ahmed N, Asokan A, Boye SE, Crystal RG, De Oliveira S, Gargiulo L, Harper SQ, Ikeda Y, Jambou R, Montgomery M, et al. Gene therapy: charting a future course--summary of a National Institutes of Health Workshop, April 12, 2013. Human Gene Therapy. 25: 488-97. PMID 24773122 DOI: 10.1089/Hum.2014.045  0.324
2013 Asokan A, Samulski RJ. An emerging adeno-associated viral vector pipeline for cardiac gene therapy. Human Gene Therapy. 24: 906-13. PMID 24164238 DOI: 10.1089/Hum.2013.2515  0.423
2013 Shen S, Troupes AN, Pulicherla N, Asokan A. Multiple roles for sialylated glycans in determining the cardiopulmonary tropism of adeno-associated virus 4. Journal of Virology. 87: 13206-13. PMID 24067974 DOI: 10.1128/Jvi.02109-13  0.619
2013 Shen S, Horowitz ED, Troupes AN, Brown SM, Pulicherla N, Samulski RJ, Agbandje-McKenna M, Asokan A. Engraftment of a galactose receptor footprint onto adeno-associated viral capsids improves transduction efficiency. The Journal of Biological Chemistry. 288: 28814-23. PMID 23940044 DOI: 10.1074/Jbc.M113.482380  0.602
2013 Horowitz ED, Rahman KS, Bower BD, Dismuke DJ, Falvo MR, Griffith JD, Harvey SC, Asokan A. Biophysical and ultrastructural characterization of adeno-associated virus capsid uncoating and genome release. Journal of Virology. 87: 2994-3002. PMID 23269804 DOI: 10.1128/Jvi.03017-12  0.33
2012 Asokan A, Schaffer DV, Jude Samulski R. The AAV Vector Toolkit: Poised at the Clinical Crossroads. Molecular Therapy : the Journal of the American Society of Gene Therapy. 20: 699-708. PMID 28160612 DOI: 10.1038/mt.2011.287  0.33
2012 Shen S, Bryant KD, Sun J, Brown SM, Troupes A, Pulicherla N, Asokan A. Glycan binding avidity determines the systemic fate of adeno-associated virus type 9. Journal of Virology. 86: 10408-17. PMID 22787229 DOI: 10.1128/Jvi.01155-12  0.614
2012 Li C, Diprimio N, Bowles DE, Hirsch ML, Monahan PE, Asokan A, Rabinowitz J, Agbandje-McKenna M, Samulski RJ. Single amino acid modification of adeno-associated virus capsid changes transduction and humoral immune profiles. Journal of Virology. 86: 7752-9. PMID 22593151 DOI: 10.1128/Jvi.00675-12  0.429
2012 Denard J, Beley C, Kotin R, Lai-Kuen R, Blot S, Leh H, Asokan A, Samulski RJ, Moullier P, Voit T, Garcia L, Svinartchouk F. Human galectin 3 binding protein interacts with recombinant adeno-associated virus type 6. Journal of Virology. 86: 6620-31. PMID 22496229 DOI: 10.1128/Jvi.00297-12  0.41
2012 Horowitz ED, Finn MG, Asokan A. Tyrosine cross-linking reveals interfacial dynamics in adeno-associated viral capsids during infection. Acs Chemical Biology. 7: 1059-66. PMID 22458529 DOI: 10.1021/Cb3000265  0.374
2012 Pulicherla N, Kota P, Dokholyan NV, Asokan A. Intra- and inter-subunit disulfide bond formation is nonessential in adeno-associated viral capsids. Plos One. 7: e32163. PMID 22389684 DOI: 10.1371/Journal.Pone.0032163  0.345
2012 Asokan A, Schaffer DV, Samulski RJ. The AAV vector toolkit: poised at the clinical crossroads. Molecular Therapy : the Journal of the American Society of Gene Therapy. 20: 699-708. PMID 22273577 DOI: 10.1038/Mt.2011.287  0.434
2012 Li C, Narkbunnam N, Samulski RJ, Asokan A, Hu G, Jacobson LJ, Manco-Johnson MJ, Monahan PE. Neutralizing antibodies against adeno-associated virus examined prospectively in pediatric patients with hemophilia. Gene Therapy. 19: 288-94. PMID 21697954 DOI: 10.1038/Gt.2011.90  0.427
2011 Gray SJ, Choi VW, Asokan A, Haberman RA, McCown TJ, Samulski RJ. Production of recombinant adeno-associated viral vectors and use in in vitro and in vivo administration. Current Protocols in Neuroscience / Editorial Board, Jacqueline N. Crawley ... [Et Al.]. Unit 4.17. PMID 21971848 DOI: 10.1002/0471142301.Ns0417S57  0.471
2011 Kapoor A, Hornig M, Asokan A, Williams B, Henriquez JA, Lipkin WI. Bocavirus episome in infected human tissue contains non-identical termini. Plos One. 6: e21362. PMID 21738642 DOI: 10.1371/Journal.Pone.0021362  0.337
2011 Pulicherla N, Asokan A. Peptide affinity reagents for AAV capsid recognition and purification. Gene Therapy. 18: 1020-4. PMID 21490687 DOI: 10.1038/Gt.2011.46  0.316
2011 Horowitz ED, Weinberg MS, Asokan A. Glycated AAV vectors: chemical redirection of viral tissue tropism. Bioconjugate Chemistry. 22: 529-32. PMID 21388193 DOI: 10.1021/Bc100477G  0.452
2011 Pulicherla N, Shen S, Yadav S, Debbink K, Govindasamy L, Agbandje-McKenna M, Asokan A. Engineering liver-detargeted AAV9 vectors for cardiac and musculoskeletal gene transfer. Molecular Therapy : the Journal of the American Society of Gene Therapy. 19: 1070-8. PMID 21364538 DOI: 10.1038/Mt.2011.22  0.618
2011 Shen S, Bryant KD, Brown SM, Randell SH, Asokan A. Terminal N-linked galactose is the primary receptor for adeno-associated virus 9. The Journal of Biological Chemistry. 286: 13532-40. PMID 21330365 DOI: 10.1074/Jbc.M110.210922  0.613
2011 Phillips JL, Hegge J, Wolff JA, Samulski RJ, Asokan A. Systemic gene transfer to skeletal muscle using reengineered AAV vectors. Methods in Molecular Biology (Clifton, N.J.). 709: 141-51. PMID 21194026 DOI: 10.1007/978-1-61737-982-6_9  0.405
2010 Asokan A. Reengineered AAV vectors: old dog, new tricks. Discovery Medicine. 9: 399-403. PMID 20515607  0.326
2010 Asokan A, Conway JC, Phillips JL, Li C, Hegge J, Sinnott R, Yadav S, DiPrimio N, Nam HJ, Agbandje-McKenna M, McPhee S, Wolff J, Samulski RJ. Reengineering a receptor footprint of adeno-associated virus enables selective and systemic gene transfer to muscle. Nature Biotechnology. 28: 79-82. PMID 20037580 DOI: 10.1038/Nbt.1599  0.467
2009 Li C, Goudy K, Hirsch M, Asokan A, Fan Y, Alexander J, Sun J, Monahan P, Seiber D, Sidney J, Sette A, Tisch R, Frelinger J, Samulski RJ. Cellular immune response to cryptic epitopes during therapeutic gene transfer. Proceedings of the National Academy of Sciences of the United States of America. 106: 10770-4. PMID 19541644 DOI: 10.1073/Pnas.0902269106  0.365
2009 Li C, Hirsch M, DiPrimio N, Asokan A, Goudy K, Tisch R, Samulski RJ. Cytotoxic-T-lymphocyte-mediated elimination of target cells transduced with engineered adeno-associated virus type 2 vector in vivo. Journal of Virology. 83: 6817-24. PMID 19369348 DOI: 10.1128/Jvi.00278-09  0.427
2009 Li C, Hirsch M, Carter P, Asokan A, Zhou X, Wu Z, Samulski RJ. A small regulatory element from chromosome 19 enhances liver-specific gene expression. Gene Therapy. 16: 43-51. PMID 18701910 DOI: 10.1038/Gt.2008.134  0.409
2008 Li W, Asokan A, Wu Z, Van Dyke T, DiPrimio N, Johnson JS, Govindaswamy L, Agbandje-McKenna M, Leichtle S, Eugene Redmond D, McCown TJ, Petermann KB, Sharpless NE, Samulski RJ. Engineering and Selection of Shuffled AAV Genomes: A New Strategy for Producing Targeted Biological Nanoparticles. Molecular Therapy : the Journal of the American Society of Gene Therapy. 16: 1252-1260. PMID 28178482 DOI: 10.1038/Mt.2008.100  0.476
2008 Asokan A, Johnson JS, Li C, Samulski RJ. Bioluminescent virion shells: new tools for quantitation of AAV vector dynamics in cells and live animals. Gene Therapy. 15: 1618-22. PMID 18668144 DOI: 10.1038/Gt.2008.127  0.437
2008 Li W, Asokan A, Wu Z, Van Dyke T, DiPrimio N, Johnson JS, Govindaswamy L, Agbandje-McKenna M, Leichtle S, Redmond DE, McCown TJ, Petermann KB, Sharpless NE, Samulski RJ. Engineering and selection of shuffled AAV genomes: a new strategy for producing targeted biological nanoparticles. Molecular Therapy : the Journal of the American Society of Gene Therapy. 16: 1252-60. PMID 18500254 DOI: 10.1038/mt.2008.100  0.38
2008 DiPrimio N, Asokan A, Govindasamy L, Agbandje-McKenna M, Samulski RJ. Surface loop dynamics in adeno-associated virus capsid assembly. Journal of Virology. 82: 5178-89. PMID 18367523 DOI: 10.1128/Jvi.02721-07  0.385
2007 Choi VW, Asokan A, Haberman RA, Samulski RJ. Production of recombinant adeno-associated viral vectors. Current Protocols in Human Genetics / Editorial Board, Jonathan L. Haines ... [Et Al.]. Unit 12.9. PMID 18428408 DOI: 10.1002/0471142905.Hg1209S53  0.464
2007 Choi VW, Asokan A, Haberman RA, Samulski RJ. Production of recombinant adeno-associated viral vectors for in vitro and in vivo use. Current Protocols in Molecular Biology / Edited by Frederick M. Ausubel ... [Et Al.]. Unit 16.25. PMID 18265393 DOI: 10.1002/0471142727.Mb1625S78  0.474
2007 Li C, Hirsch M, Asokan A, Zeithaml B, Ma H, Kafri T, Samulski RJ. Adeno-associated virus type 2 (AAV2) capsid-specific cytotoxic T lymphocytes eliminate only vector-transduced cells coexpressing the AAV2 capsid in vivo. Journal of Virology. 81: 7540-7. PMID 17475652 DOI: 10.1128/Jvi.00529-07  0.463
2006 Choi VW, Asokan A, Haberman RA, McCown TJ, Samulski RJ. Production of recombinant adeno-associated viral vectors and use for in vitro and in vivo administration. Current Protocols in Neuroscience / Editorial Board, Jacqueline N. Crawley ... [Et Al.]. Unit 4.17. PMID 18428636 DOI: 10.1002/0471142301.ns0417s35  0.378
2006 Wu Z, Asokan A, Grieger JC, Govindasamy L, Agbandje-McKenna M, Samulski RJ. Single amino acid changes can influence titer, heparin binding, and tissue tropism in different adeno-associated virus serotypes. Journal of Virology. 80: 11393-7. PMID 16943302 DOI: 10.1128/Jvi.01288-06  0.463
2006 Asokan A, Hamra JB, Govindasamy L, Agbandje-McKenna M, Samulski RJ. Adeno-associated virus type 2 contains an integrin alpha5beta1 binding domain essential for viral cell entry. Journal of Virology. 80: 8961-9. PMID 16940508 DOI: 10.1128/Jvi.00843-06  0.413
2006 Wu Z, Asokan A, Samulski RJ. Adeno-associated virus serotypes: vector toolkit for human gene therapy. Molecular Therapy : the Journal of the American Society of Gene Therapy. 14: 316-27. PMID 16824801 DOI: 10.1016/J.Ymthe.2006.05.009  0.488
2006 Asokan A, Samulski RJ. AAV does the shuffle. Nature Biotechnology. 24: 158-60. PMID 16465157 DOI: 10.1038/Nbt0206-158  0.408
2006 Asokan A, Johnson JS, Samulski RJ. 739. Bioluminescent Virion Shells: A Novel Tool for Visualization of Viral Vectors in Animal Tissue Molecular Therapy. 13: S286. DOI: 10.1016/J.Ymthe.2006.08.821  0.461
2006 DiPrimio N, Asokan A, Samulski RJ. 104. Role of the HI Loop in the Adeno- Associated Virus (AAV) Life Cycle Molecular Therapy. 13: S43. DOI: 10.1016/J.Ymthe.2006.08.124  0.402
2006 Asokan A, Hamra JB, Agbandje-McKenna M, Samulski RJ. 7. Adeno-Associated Virus Type 2 (AAV2) Contains an Integrin alpha5beta1 Recognition Sequence Essential for Viral Cell Entry Molecular Therapy. 13: S3. DOI: 10.1016/J.Ymthe.2006.08.017  0.415
2005 Asokan A, Samulski RJ. From crystal structure to clinic: highlights of the Tenth International Parvovirus Workshop. Molecular Therapy : the Journal of the American Society of Gene Therapy. 11: 656-60. PMID 15892211 DOI: 10.1016/J.Ymthe.2005.03.014  0.378
2003 Chen FJ, Asokan A, Cho MJ. Cytosolic delivery of macromolecules: I. Synthesis and characterization of pH-sensitive acyloxyalkylimidazoles. Biochimica Et Biophysica Acta. 1611: 140-50. PMID 12659955 DOI: 10.1016/S0005-2736(03)00049-X  0.303
Low-probability matches (unlikely to be authored by this person)
2019 Asokan A. CRISPR genome editing in stem cells turns to gold. Nature Materials. 18: 1038-1039. PMID 31537943 DOI: 10.1038/S41563-019-0491-4  0.3
2021 Emmanuel SN, Smith JK, Hsi J, Tseng YS, Kaplan M, Mietzsch M, Chipman P, Asokan A, McKenna R, Agbandje-McKenna M. Structurally Mapping Antigenic Epitopes of Adeno-Associated Virus 9: Development of Antibody Escape Variants. Journal of Virology. JVI0125121. PMID 34757842 DOI: 10.1128/JVI.01251-21  0.298
2021 Gemberling MP, Siklenka K, Rodriguez E, Tonn-Eisinger KR, Barrera A, Liu F, Kantor A, Li L, Cigliola V, Hazlett MF, Williams CA, Bartelt LC, Madigan VJ, Bodle JC, Daniels H, ... ... Asokan A, et al. Transgenic mice for in vivo epigenome editing with CRISPR-based systems. Nature Methods. PMID 34341582 DOI: 10.1038/s41592-021-01207-2  0.297
2021 Pickar-Oliver A, Gough V, Bohning JD, Liu S, Robinson-Hamm JN, Daniels H, Majoros WH, Devlin G, Asokan A, Gersbach CA. Full-length Dystrophin Restoration via Targeted Genomic Integration by AAV-CRISPR in a Humanized Mouse Model of Duchenne Muscular Dystrophy. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 34509668 DOI: 10.1016/j.ymthe.2021.09.003  0.294
2004 Asokan A, Cho MJ. Cytosolic delivery of macromolecules. 3. Synthesis and characterization of acid-sensitive bis-detergents. Bioconjugate Chemistry. 15: 1166-73. PMID 15546181 DOI: 10.1021/Bc049880N  0.293
2005 Asokan A, Cho MJ. Cytosolic delivery of macromolecules 4. Head group-dependent membrane permeabilization by pH-sensitive detergents. Journal of Controlled Release : Official Journal of the Controlled Release Society. 106: 146-53. PMID 15979190 DOI: 10.1016/J.Jconrel.2005.04.010  0.292
2002 Asokan A, Cho MJ. Exploitation of intracellular pH gradients in the cellular delivery of macromolecules. Journal of Pharmaceutical Sciences. 91: 903-13. PMID 11948528 DOI: 10.1002/Jps.10095  0.292
2015 Borchardt EK, Vandoros LA, Huang M, Lackey PE, Marzluff WF, Asokan A. Controlling mRNA stability and translation with the CRISPR endoribonuclease Csy4. Rna (New York, N.Y.). PMID 26354771 DOI: 10.1261/Rna.051227.115  0.287
2018 Mestre H, Hablitz LM, Xavier AL, Feng W, Zou W, Pu T, Monai H, Murlidharan G, Castellanos Rivera RM, Simon MJ, Pike MM, Plá V, Du T, Kress BT, Wang X, ... ... Asokan A, et al. Aquaporin-4-dependent glymphatic solute transport in the rodent brain. Elife. 7. PMID 30561329 DOI: 10.7554/Elife.40070  0.279
2003 Asokan A, Cho MJ. Cytosolic delivery of macromolecules. II. Mechanistic studies with pH-sensitive morpholine lipids. Biochimica Et Biophysica Acta. 1611: 151-60. PMID 12659956 DOI: 10.1016/S0005-2736(03)00050-6  0.278
2017 Borchardt EK, Meganck RM, Vincent HA, Ball CB, Ramos SB, Moorman NJ, Marzluff WF, Asokan A. Inducing circular RNA formation using the CRISPR endoribonuclease Csy4. Rna (New York, N.Y.). PMID 28223408 DOI: 10.1261/Rna.056838.116  0.278
2020 Kang MH, Hu J, Pratt RE, Hodgkinson CP, Asokan A, Dzau VJ. Optimizing delivery for efficient cardiac reprogramming. Biochemical and Biophysical Research Communications. PMID 32917363 DOI: 10.1016/J.Bbrc.2020.08.104  0.273
2023 Konkimalla A, Elmore Z, Konishi S, Macadlo L, Katsura H, Tata A, Asokan A, Tata PR. Efficient AAV Mediated Transgenesis in Alveolar Stem Cells and Associated Niches. American Journal of Respiratory Cell and Molecular Biology. PMID 37315312 DOI: 10.1165/rcmb.2022-0424MA  0.252
2017 Guo J, Otis JM, Higginbotham H, Monckton C, Cheng J, Asokan A, Mykytyn K, Caspary T, Stuber GD, Anton ES. Primary Cilia Signaling Shapes the Development of Interneuronal Connectivity. Developmental Cell. 42: 286-300.e4. PMID 28787594 DOI: 10.1016/J.Devcel.2017.07.010  0.248
2024 Loeb EJ, Havlik PL, Elmore ZC, Rosales A, Fergione SM, Gonzalez TJ, Smith TJ, Benkert AR, Fiflis DN, Asokan A. Capsid-mediated control of adeno-associated viral transcription determines host range. Cell Reports. 43: 113902. PMID 38431840 DOI: 10.1016/j.celrep.2024.113902  0.247
2021 Das A, Vijayan M, Walton EM, Stafford VG, Fiflis DN, Asokan A. Epigenetic silencing of recombinant AAV genomes by NP220 and the HUSH complex. Journal of Virology. JVI0203921. PMID 34878926 DOI: 10.1128/JVI.02039-21  0.245
2023 Barzi M, Johnson CG, Chen T, Rodriguiz RM, Hemmingsen M, Gonzalez TJ, Rosales A, Beasley J, Peck CK, Ma Y, Stiles AR, Wood TC, Maeso-Diaz R, Diehl AM, Young SP, ... ... Asokan A, et al. Rescue of glutaric aciduria type I in mice by liver-directed therapies. Science Translational Medicine. 15: eadf4086. PMID 37075130 DOI: 10.1126/scitranslmed.adf4086  0.236
2023 Asokan A. AAV vector immunotoxicity: Stopping the domino effect. Molecular Therapy : the Journal of the American Society of Gene Therapy. 31: 3357-3358. PMID 37989317 DOI: 10.1016/j.ymthe.2023.11.016  0.23
2015 Li C, Wu S, Albright B, Hirsch M, Li W, Tseng YS, Agbandje-McKenna M, McPhee S, Asokan A, Samulski RJ. Development of Patient-specific AAV Vectors After Neutralizing Antibody Selection for Enhanced Muscle Gene Transfer Molecular Therapy. DOI: 10.1038/mt.2015.134  0.23
2023 Nyberg WA, Ark J, To A, Clouden S, Reeder G, Muldoon JJ, Chung JY, Xie WH, Allain V, Steinhart Z, Chang C, Talbot A, Kim S, Rosales A, Havlik LP, ... ... Asokan A, et al. An evolved AAV variant enables efficient genetic engineering of murine T cells. Cell. PMID 36638795 DOI: 10.1016/j.cell.2022.12.022  0.228
2023 Gao Q, Kahan R, Gonzalez TJ, Zhang M, Alderete IS, DeLaura I, Kesseli SJ, Song M, Asokan A, Barbas AS, Hartwig MG. Gene Delivery Followed by Ex Vivo Lung Perfusion using an Adeno-Associated Viral Vector in a Rodent Lung Transplant Model. The Journal of Thoracic and Cardiovascular Surgery. PMID 37678606 DOI: 10.1016/j.jtcvs.2023.08.047  0.228
2016 Murlidharan G, Samulski RJ, Asokan A. Gene therapy of CNS disorders using recombinant AAV vectors Translational Neuroscience: Fundamental Approaches For Neurological Disorders. 9-24. DOI: 10.1007/978-1-4899-7654-3_2  0.224
2022 Kesseli SJ, Krischak MK, Gao Q, Gonzalez T, Zhang M, Halpern SE, Kahan R, Song M, Huffman N, Xu H, Abraham N, Asokan A, Barbas AS, Hartwig MG. Adeno-associated virus mediates gene transduction after static cold storage treatment in rodent lung transplantation. The Journal of Thoracic and Cardiovascular Surgery. 166: e38-e49. PMID 38501313 DOI: 10.1016/j.jtcvs.2022.08.050  0.218
2018 Mestre H, Hablitz LM, Xavier AL, Feng W, Zou W, Pu T, Monai H, Murlidharan G, Rivera RMC, Simon MJ, Pike MM, Plá V, Du T, Kress BT, Wang X, ... ... Asokan A, et al. Author response: Aquaporin-4-dependent glymphatic solute transport in the rodent brain Elife. DOI: 10.7554/Elife.40070.022  0.215
2024 Kurt E, Devlin G, Asokan A, Segura T. Gene Delivery From Granular Scaffolds for Tunable Biologics Manufacturing. Small (Weinheim An Der Bergstrasse, Germany). e2309911. PMID 38462954 DOI: 10.1002/smll.202309911  0.202
2021 Saha K, Sontheimer EJ, Brooks PJ, Dwinell MR, Gersbach CA, Liu DR, Murray SA, Tsai SQ, Wilson RC, Anderson DG, Asokan A, Banfield JF, Bankiewicz KS, Bao G, Bulte JWM, et al. The NIH Somatic Cell Genome Editing program. Nature. 592: 195-204. PMID 33828315 DOI: 10.1038/s41586-021-03191-1  0.193
2021 Meganck RM, Liu J, Hale AE, Simon KE, Fanous MM, Vincent HA, Wilusz JE, Moorman NJ, Marzluff WF, Asokan A. Engineering highly efficient backsplicing and translation of synthetic circRNAs. Molecular Therapy. Nucleic Acids. 23: 821-834. PMID 33614232 DOI: 10.1016/j.omtn.2021.01.003  0.191
2023 Grigsby D, Klingeborn M, Kelly U, Chew LA, Asokan A, Devlin G, Smith S, Keyes L, Timmers A, Scaria A, Bowes Rickman C. AAV Gene Augmentation of Truncated Complement Factor H Differentially Rescues Ocular Complement Dysregulation in a Mouse Model. Investigative Ophthalmology & Visual Science. 64: 25. PMID 37471073 DOI: 10.1167/iovs.64.10.25  0.189
2021 Cannon P, Asokan A, Czechowicz A, Hammond P, Kohn DB, Lieber A, Malik P, Marks P, Porteus M, Verhoeyen E, Weissman D, Weissman I, Kiem HP. Safe and Effective In Vivo Targeting and Gene Editing in Hematopoietic Stem Cells: Strategies for Accelerating Development National Institutes of Health/Bill & Melinda Gates Foundation Expert Scientific Roundtable Webinar Meeting. Human Gene Therapy. PMID 33427035 DOI: 10.1089/hum.2020.263  0.18
2022 Gao Q, DeLaura IF, Anwar IJ, Kesseli SJ, Kahan R, Abraham N, Asokan A, Barbas AS, Hartwig MG. Gene Therapy: Will the Promise of Optimizing Lung Allografts Become Reality? Frontiers in Immunology. 13: 931524. PMID 35844566 DOI: 10.3389/fimmu.2022.931524  0.17
2015 Chiang YM, Ahuja M, Oakley CE, Entwistle R, Asokan A, Zutz C, Wang CC, Oakley BR. Development of Genetic Dereplication Strains in Aspergillus nidulans Results in the Discovery of Aspercryptin. Angewandte Chemie (International Ed. in English). PMID 26563584 DOI: 10.1002/Anie.201507097  0.152
2006 Asokan A, Cheung R, Cho MJ. Strategies for the Cytosolic Delivery of Macromolecules: An Overview Handbook of Pharmaceutical Biotechnology. 279-296. DOI: 10.1002/9780470117118.ch3c  0.151
2022 Vekstein AM, Wendell DC, DeLuca S, Yan R, Chen Y, Bishawi M, Devlin GW, Asokan A, Poss KD, Bowles DE, Williams AR, Bursac N. Targeted Delivery for Cardiac Regeneration: Comparison of Intra-coronary Infusion and Intra-myocardial Injection in Porcine Hearts. Frontiers in Cardiovascular Medicine. 9: 833335. PMID 35224061 DOI: 10.3389/fcvm.2022.833335  0.151
2016 Thomas S, Ravishankaran S, Justin JA, Asokan A, Mathai MT, Valecha N, Thomas MB, Eapen A. Overhead tank is the potential breeding habitat of Anopheles stephensi in an urban transmission setting of Chennai, India. Malaria Journal. 15: 274. PMID 27169513 DOI: 10.1186/S12936-016-1321-7  0.15
2022 Konkimalla A, Konishi S, Kobayashi Y, Kadur Lakshminarasimha Murthy P, Macadlo L, Mukherjee A, Elmore Z, Kim SJ, Pendergast AM, Lee PJ, Asokan A, Knudsen L, Bravo-Cordero JJ, Tata A, Tata PR. Multi-apical polarity of alveolar stem cells and their dynamics during lung development and regeneration. Iscience. 25: 105114. PMID 36185377 DOI: 10.1016/j.isci.2022.105114  0.132
2021 Gibson RA, Lim JA, Choi SJ, Flores L, Clinton L, Bali D, Young S, Asokan A, Sun B, Kishnani PS. Characterization of liver GSD IX γ2 pathophysiology in a novel Phkg2 mouse model. Molecular Genetics and Metabolism. PMID 34083142 DOI: 10.1016/j.ymgme.2021.05.008  0.126
2024 Smith TJ, Elmore ZC, Fusco RM, Hull JA, Rosales A, Martinez M, Tarantal AF, Asokan A. Engineered IgM and IgG cleaving enzymes for mitigating antibody neutralization and complement activation in AAV gene transfer. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 38715362 DOI: 10.1016/j.ymthe.2024.05.004  0.12
2023 Cigliola V, Shoffner A, Lee N, Ou J, Gonzalez TJ, Hoque J, Becker CJ, Han Y, Shen G, Faw TD, Abd-El-Barr MM, Varghese S, Asokan A, Poss KD. Spinal cord repair is modulated by the neurogenic factor Hb-egf under direction of a regeneration-associated enhancer. Nature Communications. 14: 4857. PMID 37567873 DOI: 10.1038/s41467-023-40486-5  0.117
2024 Fiflis DN, Rey NA, Venugopal-Lavanya H, Sewell B, Mitchell-Dick A, Clements KN, Milo S, Benkert AR, Rosales A, Fergione S, Asokan A. Repurposing CRISPR-Cas13 systems for robust mRNA trans-splicing. Nature Communications. 15: 2325. PMID 38485709 DOI: 10.1038/s41467-024-46172-4  0.117
2001 Asokan A, de Ropp JS, Newmyer SL, Ortiz de Montellano PR, La Mar GN. Solution 1H NMR of the molecular and electronic structure of the heme cavity and substrate binding pocket of high-spin ferric horseradish peroxidase: effect of His42Ala mutation. Journal of the American Chemical Society. 123: 4243-54. PMID 11457190 DOI: 10.1021/ja003687w  0.113
2024 Zhu X, Huang Q, Jiang L, Nguyen VT, Vu T, Devlin G, Shaima J, Wang X, Chen Y, Ma L, Xiang K, Wang E, Rong Q, Zhou Q, Kang Y, ... Asokan A, et al. Longitudinal intravital imaging of mouse placenta. Science Advances. 10: eadk1278. PMID 38507481 DOI: 10.1126/sciadv.adk1278  0.112
2002 de Ropp JS, Sham S, Asokan A, Newmyer S, Ortiz de Montellano PR, La Mar GN. Influence of the distal his in imparting imidazolate character to the proximal his in heme peroxidase: (1)h NMR spectroscopic study of cyanide-inhibited his42-->ala horseradish peroxidase. Journal of the American Chemical Society. 124: 11029-37. PMID 12224950 DOI: 10.1021/ja020176w  0.092
2001 La Mar GN, Asokan A, Espiritu B, Yeh DC, Auclair K, Ortiz De Montellano PR. Solution 1H NMR of the active site of substrate-bound, cyanide-inhibited human heme oxygenase. comparison to the crystal structure of the water-ligated form. The Journal of Biological Chemistry. 276: 15676-87. PMID 11297521 DOI: 10.1074/Jbc.M009974200  0.088
2014 Asokan A, Ball AR, Laird CD, Hermer L, Ormerod BK. Desvenlafaxine may accelerate neuronal maturation in the dentate gyri of adult male rats. Plos One. 9: e98530. PMID 24896246 DOI: 10.1371/Journal.Pone.0098530  0.086
2016 van Eijk AM, Ramanathapuram L, Sutton PL, Peddy N, Choubey S, Mohanty S, Asokan A, Ravishankaran S, Priya GS, Johnson JA, Velayutham S, Kanagaraj D, Patel A, Desai N, Tandel N, et al. The use of mosquito repellents at three sites in India with declining malaria transmission: surveys in the community and clinic. Parasites & Vectors. 9: 418. PMID 27465199 DOI: 10.1186/s13071-016-1709-9  0.07
2016 Nagarajan M, Asokan A, Manikandan M, Sivakumar D. Design and implementation of fractional order controller for heat exchanger Arpn Journal of Engineering and Applied Sciences. 11: 2016-2022.  0.065
2011 Olarte R, Bared JG, Sutherland LF, Asokan A. Density models and safety analysis for rural unsignalised restricted crossing U-turn intersections Procedia - Social and Behavioral Sciences. 16: 718-728. DOI: 10.1016/j.sbspro.2011.04.491  0.063
2016 van Eijk AM, Ramanathapuram L, Sutton PL, Kanagaraj D, Sri Lakshmi Priya G, Ravishankaran S, Asokan A, Tandel N, Patel A, Desai N, Singh R, Sullivan SA, Carlton JM, Srivastava HC, Eapen A. What is the value of reactive case detection in malaria control? A case-study in India and a systematic review. Malaria Journal. 15: 67. PMID 26852118 DOI: 10.1186/s12936-016-1120-1  0.06
2014 Mohanrao R, Asokan A, Sureshan KM. Bio-inspired synthesis of rare and unnatural carbohydrates and cyclitols through strain driven epimerization. Chemical Communications (Cambridge, England). 50: 6707-10. PMID 24668007 DOI: 10.1039/C4Cc00868E  0.056
2013 Asokan AG, D'souza S, Jeganathan J, Pai S. Fahr's Syndrome- An Interesting Case Presentation. Journal of Clinical and Diagnostic Research : Jcdr. 7: 532-3. PMID 23634413 DOI: 10.7860/JCDR/2013/4946.2814  0.054
2013 Ormerod BK, Hanft SJ, Asokan A, Haditsch U, Lee SW, Palmer TD. PPARγ activation prevents impairments in spatial memory and neurogenesis following transient illness. Brain, Behavior, and Immunity. 29: 28-38. PMID 23108061 DOI: 10.1016/J.Bbi.2012.10.017  0.051
2021 Mitchell-Dick A, Asokan A. AAV-CNS matters turn from gray to white. Molecular Therapy : the Journal of the American Society of Gene Therapy. 29: 1659-1660. PMID 33891861 DOI: 10.1016/j.ymthe.2021.04.012  0.051
2016 Mathew AP, Asokan A, Batri K. Development of a video signal based non-invasive method for measurement of turbulent flame temperature Arpn Journal of Engineering and Applied Sciences. 11: 1717-1723.  0.046
2014 Chittoria RK, Mohapatra DP, Friji MT, Kumar SD, Asokan A, Pandey S. Camphor burns of the palm and non-suicidal self-injury: An uncommonly reported, but socially relevant issue. Indian Journal of Plastic Surgery : Official Publication of the Association of Plastic Surgeons of India. 47: 252-5. PMID 25190924 DOI: 10.4103/0970-0358.138968  0.046
2015 Scheinert RB, Asokan A, Rani A, Kumar A, Foster TC, Ormerod BK. Some hormone, cytokine and chemokine levels that change across lifespan vary by cognitive status in male Fischer 344 rats. Brain, Behavior, and Immunity. PMID 26093306 DOI: 10.1016/J.Bbi.2015.06.005  0.045
1999 Asokan A, Manoharan PT. 1H NMR studies on strongly antiferromagnetically coupled dicopper(II) systems Inorganic Chemistry. 38: 5642-5654.  0.045
2016 Mathew AP, Asokan A, Batri K, Sivakumar D. Comparative analysis of flame image features for combustion analysis Indian Journal of Science and Technology. 9. DOI: 10.17485/ijst/2016/v9i6/79904  0.043
2009 Bhattacharyya R, Asokan A, Bhattacharya P, Prasad R. The potential of certification for conservation and management of wild MAP resources Biodiversity and Conservation. 18: 3441-3451. DOI: 10.1007/s10531-009-9653-z  0.04
2016 Pochareddy YK, Ganeshram AK, Pyarelal HM, Sridharan S, Asokan A, Dhamodaran G, Duraisamy P. Performance and emission characteristics of a stationary direct injection compression ignition engine fuelled with diethyl ether–sapote seed oil methyl ester–diesel blends Biofuels. 8: 297-305. DOI: 10.1080/17597269.2016.1225646  0.034
1999 Asokan A, Varghese B, Manoharan PT. Synthesis, structure, magnetic properties, and1H NMR studies of a moderately antiferromagnetically coupled binuclear copper(II) complex Inorganic Chemistry. 38: 4393-4399.  0.033
2018 Rejikumar G, Asokan AA, Kumar VG. Pharmaceutical Marketing: Directions for Customer Orientation Research Journal of Pharmacy and Technology. 11: 3283. DOI: 10.5958/0974-360X.2018.00604.2  0.03
2008 Bhattacharya P, Prasad R, Bhattacharyya R, Asokan A. Towards certification of wild medicinal and aromatic plants in four Indian states Unasylva. 59: 35-44.  0.03
1992 Asokan A, Fancourt GJ, Bennett SE, Castleden CM. Renal prostaglandins, effective renal plasma flow and glomerular filtration rate in healthy elderly subjects. Age and Ageing. 21: 39-42. PMID 1553858  0.027
1995 Asokan A, Manual PK, Varghese B, Manoharan PT. Structure and magnetism of an exchange coupled system: An NMR approach Proceedings of the Indian Academy of Sciences - Chemical Sciences. 107: 281-295. DOI: 10.1007/BF02840784  0.027
1998 Asokan A, Varghese B, Caneschi A, Manoharan PT. A Novel Polymer of a Binuclear Nickel(II) Complex Bridged by 1,3-Diaminopropane: Structure and Magnetism Inorganic Chemistry. 37: 228-232.  0.027
2008 Asokan A. Culture calling: Where is CHI? Conference On Human Factors in Computing Systems - Proceedings. 2383-2386. DOI: 10.1145/1358628.1358690  0.026
2015 Lofaro DM, Asokan A, Roderick EM. Feasibility of cloud enabled humanoid robots: Development of low latency geographically adjacent real-time cloud control Ieee-Ras International Conference On Humanoid Robots. 2015: 519-526. DOI: 10.1109/HUMANOIDS.2015.7363582  0.025
2015 Brey JA, Mills EW, Day-Miller EA, Geer IW, Weinbeck RS, Blair BA, Hopkin EJ, O’Neill KL, Nugnes KA, Asokan A. The ams datastreme earth’s climate system teacher professional development course: Results from a three-year study Journal of Geoscience Education. 63: 47-56. DOI: 10.5408/13-038.1  0.025
2004 Asokan A, Kelsall RW. Monte carlo simulations of phonon transport in silicon 2004 10th International Workshop On Computational Electronics, Ieee Iwce-10 2004, Abstracts. 55.  0.024
2009 Asokan A, Sivakumar D. Fault detection and diagnosis for three-tank system using robust residual generator Indian Journal of Science and Technology. 2. DOI: 10.17485/ijst/2009/v2i7/29492  0.024
2007 Bhaba PK, Sathishbabu S, Asokan A, Karunanithi T. Real time implementation of Wiener Model PI (WMPI) controller in a conical tank liquid level process Journal of Applied Sciences. 7: 2194-2197.  0.023
2002 Asokan A, Madhu G. Industrial pollution: Modern abatement approach Chemical Engineering World. 37: 100-103.  0.022
2016 Lofaro DM, Asokan A. Low latency bounty hunting and geographically adjacent server configuration for real-time cloud control Proceedings - Ieee International Conference On Robotics and Automation. 2016: 5277-5282. DOI: 10.1109/ICRA.2016.7487738  0.021
2008 Sengupta AK, Asokan A. Modelling of masonry infill walls for nonlinear static analysis of buildings Indian Concrete Journal. 82: 19-28.  0.019
2013 Asokan AT. Reflections on adivasi silence: An interview with the eminent activist for tribal rights and environmental crusader Mahasweta Devi Asiatic. 7: 154-162.  0.018
1999 Manickavasagam RM, Jain AK, Singh S, Asokan A. Metamorphic evolution of the northwest Himalaya, India: Pressure-temperature data, inverted metamorphism, and exhumation in the Kashmir, Himachal, and Garhwal Himalayas Special Paper of the Geological Society of America. 328: 179-198. DOI: 10.1130/0-8137-2328-0.179  0.018
2016 Asokan A, Kambalimath HV, Patil RU, Maran S, Bharath KP. A survey of the dentist attire and gender preferences in dentally anxious children. Journal of the Indian Society of Pedodontics and Preventive Dentistry. 34: 30-5. PMID 26838145 DOI: 10.4103/0970-4388.175507  0.016
2015 Asokan A, Bosio A, Virazel A, Dilillo L, Girard P, Pravossoudovitch S. An ATPG flow to generate crosstalk-aware path delay pattern Proceedings of Ieee Computer Society Annual Symposium On Vlsi, Isvlsi. 7: 515-520. DOI: 10.1109/ISVLSI.2015.99  0.016
2004 Asokan A, Saxena M, Pappu A. Fungal ergosterol as an indicator of heavy metal accumulation in soils amended with coal ash Fresenius Environmental Bulletin. 13: 16-20.  0.012
2014 Asokan A, Todri-Sanial A, Bosio A, Dilillo L, Girard P, Pravossoudovitch S, Virazel A. Path delay test in the presence of multi-aggressor crosstalk, power supply noise and ground bounce Proceedings of the 2014 Ieee 17th International Symposium On Design and Diagnostics of Electronic Circuits and Systems, Ddecs 2014. 207-212. DOI: 10.1109/DDECS.2014.6868791  0.01
2015 Brey JA, Geer IW, Mills EW, Nugnes KA, Asokan A. Energizing students' earth science literacy 2014 Oceans - St. John's, Oceans 2014. DOI: 10.1109/OCEANS.2014.7003014  0.01
2014 George SE, Sreevidya A, Asokan A, Mahadevan V. Klippel Trenaunay syndrome and the anaesthesiologist. Indian Journal of Anaesthesia. 58: 775-7. PMID 25624555 DOI: 10.4103/0019-5049.147161  0.01
2014 Asokan A, Todri-Sanial A, Bosio A, Dilillo L, Girard P, Pravossoudovitch S, Virazel A. A delay probability metric for input pattern ranking under process variation and supply noise Proceedings of Ieee Computer Society Annual Symposium On Vlsi, Isvlsi. 226-231. DOI: 10.1109/ISVLSI.2014.42  0.01
2014 Asokan A, Ayyappadas R. Survey on cognitive radio and cognitive radio sensor networks 2014 International Conference On Electronics and Communication Systems, Icecs 2014. DOI: 10.1109/ECS.2014.6892784  0.01
2008 Asokan A, Payne MJ. Healthy technology: A metaphor that pushed user experience to new strategic heights at Intel Conference On Human Factors in Computing Systems - Proceedings. 2053-2065. DOI: 10.1145/1358628.1358637  0.01
1993 Patel RC, Singh S, Asokan A, Manickavasagam RM, Jain AK. Extensional tectonics in the Himalayan orogen, Zanskar, NW India Himalayan Tectonics. 445-459. DOI: 10.1144/GSL.SP.1993.074.01.30  0.01
1992 Asokan A, Fancourt CJ, Bennett SE, Castleden CM. Renal prostaglandins, effective renal plasma flow and glomerular filtration rate in healthy elderly subjects Journal of Age Related Disorders. 4: 16-17.  0.01
Hide low-probability matches.